RethinkHIV released a Policy Brief based on a research paper by Rifat Atun, Mthuli Ncube and Anna Vassall. Given flatlining HIV/AIDS aid flows globally and the huge future financial liabilities...read more
The moral duty to provide life-long treatment to people diagnosed with HIV, while saving millions of productive lives, creates an enduring liability that is like a debt. This burden is significant for African countries with generalised epidemics, and it has far-reaching implications.read more
RethinkHIV is a consortium of senior researchers from London School of Hygiene & Tropical Medicine, Imperial College London, Harvard School of Public Health, Centre for the Study of African Economies and Blavatnik School of Government at Oxford University.
The consortium will evaluate new evidence related to the costs, benefits, effects, fiscal implications, and developmental impacts of HIV interventions in sub-Saharan Africa, in order to maximise contributions to the fight against HIV there.
The aim of RethinkHIV is to find ways of creating, optimising, and sustaining fiscal space for domestic HIV investment, as well as exploring long-term, sustainable national and international financing mechanisms. RethinkHIV is funded by RUSH Foundation.